Cargando…

107P Impact of COVID-19 pandemic on breast cancer neoadjuvant therapy: A retrospective institutional analysis

Detalles Bibliográficos
Autores principales: Baptista Freitas, M.C., Lopes de Almeida, C., Valente, A.C., Costa, M.J., Nogueira Costa, I.C., Reis, J.S., Tavares, N.T., Dionísio de Sousa, I.J., Almeida, D.P.S., Caeiro, C.L.B., Augusto, I.M., Nunes Aguas, L.M., Barbosa, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069430/
http://dx.doi.org/10.1016/j.annonc.2022.03.123
_version_ 1784700428544376832
author Baptista Freitas, M.C.
Lopes de Almeida, C.
Valente, A.C.
Costa, M.J.
Nogueira Costa, I.C.
Reis, J.S.
Tavares, N.T.
Dionísio de Sousa, I.J.
Almeida, D.P.S.
Caeiro, C.L.B.
Augusto, I.M.
Nunes Aguas, L.M.
Barbosa, M.
author_facet Baptista Freitas, M.C.
Lopes de Almeida, C.
Valente, A.C.
Costa, M.J.
Nogueira Costa, I.C.
Reis, J.S.
Tavares, N.T.
Dionísio de Sousa, I.J.
Almeida, D.P.S.
Caeiro, C.L.B.
Augusto, I.M.
Nunes Aguas, L.M.
Barbosa, M.
author_sort Baptista Freitas, M.C.
collection PubMed
description
format Online
Article
Text
id pubmed-9069430
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-90694302022-05-04 107P Impact of COVID-19 pandemic on breast cancer neoadjuvant therapy: A retrospective institutional analysis Baptista Freitas, M.C. Lopes de Almeida, C. Valente, A.C. Costa, M.J. Nogueira Costa, I.C. Reis, J.S. Tavares, N.T. Dionísio de Sousa, I.J. Almeida, D.P.S. Caeiro, C.L.B. Augusto, I.M. Nunes Aguas, L.M. Barbosa, M. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-05 2022-05-05 /pmc/articles/PMC9069430/ http://dx.doi.org/10.1016/j.annonc.2022.03.123 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Baptista Freitas, M.C.
Lopes de Almeida, C.
Valente, A.C.
Costa, M.J.
Nogueira Costa, I.C.
Reis, J.S.
Tavares, N.T.
Dionísio de Sousa, I.J.
Almeida, D.P.S.
Caeiro, C.L.B.
Augusto, I.M.
Nunes Aguas, L.M.
Barbosa, M.
107P Impact of COVID-19 pandemic on breast cancer neoadjuvant therapy: A retrospective institutional analysis
title 107P Impact of COVID-19 pandemic on breast cancer neoadjuvant therapy: A retrospective institutional analysis
title_full 107P Impact of COVID-19 pandemic on breast cancer neoadjuvant therapy: A retrospective institutional analysis
title_fullStr 107P Impact of COVID-19 pandemic on breast cancer neoadjuvant therapy: A retrospective institutional analysis
title_full_unstemmed 107P Impact of COVID-19 pandemic on breast cancer neoadjuvant therapy: A retrospective institutional analysis
title_short 107P Impact of COVID-19 pandemic on breast cancer neoadjuvant therapy: A retrospective institutional analysis
title_sort 107p impact of covid-19 pandemic on breast cancer neoadjuvant therapy: a retrospective institutional analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069430/
http://dx.doi.org/10.1016/j.annonc.2022.03.123
work_keys_str_mv AT baptistafreitasmc 107pimpactofcovid19pandemiconbreastcancerneoadjuvanttherapyaretrospectiveinstitutionalanalysis
AT lopesdealmeidac 107pimpactofcovid19pandemiconbreastcancerneoadjuvanttherapyaretrospectiveinstitutionalanalysis
AT valenteac 107pimpactofcovid19pandemiconbreastcancerneoadjuvanttherapyaretrospectiveinstitutionalanalysis
AT costamj 107pimpactofcovid19pandemiconbreastcancerneoadjuvanttherapyaretrospectiveinstitutionalanalysis
AT nogueiracostaic 107pimpactofcovid19pandemiconbreastcancerneoadjuvanttherapyaretrospectiveinstitutionalanalysis
AT reisjs 107pimpactofcovid19pandemiconbreastcancerneoadjuvanttherapyaretrospectiveinstitutionalanalysis
AT tavaresnt 107pimpactofcovid19pandemiconbreastcancerneoadjuvanttherapyaretrospectiveinstitutionalanalysis
AT dionisiodesousaij 107pimpactofcovid19pandemiconbreastcancerneoadjuvanttherapyaretrospectiveinstitutionalanalysis
AT almeidadps 107pimpactofcovid19pandemiconbreastcancerneoadjuvanttherapyaretrospectiveinstitutionalanalysis
AT caeiroclb 107pimpactofcovid19pandemiconbreastcancerneoadjuvanttherapyaretrospectiveinstitutionalanalysis
AT augustoim 107pimpactofcovid19pandemiconbreastcancerneoadjuvanttherapyaretrospectiveinstitutionalanalysis
AT nunesaguaslm 107pimpactofcovid19pandemiconbreastcancerneoadjuvanttherapyaretrospectiveinstitutionalanalysis
AT barbosam 107pimpactofcovid19pandemiconbreastcancerneoadjuvanttherapyaretrospectiveinstitutionalanalysis